Promoted Content
Promoted Content

Overview of Digoxin

Client Email Product
DSSTox_CID_2934
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

API Market Place

INTERMEDIATES

0

DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

Dossiers Market Place

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES

0

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.
Ingredient(s): Anhydrous Lactose
Dosage Form: Tablet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 200.m

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.
Ingredient(s): Lactose Monohydrate
Dosage Form: Tablet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Sieved; Also Available as Microlex® LCM 180.s, Microlex® LCM 220.s

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Lactose monohydrate is typically used for wet or dry granulation. During wet granulation, liquid binders or adhesives are added to the lactose and active mixture, usually by blending.
Ingredient(s): Lactose Monohydrate
Dosage Form: Tablet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Tablets made from these granules are typically easily disintegrated using conventional super disintegrates even when hard tablets are compressed.
Dosage Form: Tablet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Not Available

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: The plastic defamation characteristics of  MCC 102 type mean that very hard tablets can be produced at light compaction forces, extending tooling lifetime and solving problems with poorly compressible actives.
Dosage Form: Tablet
More Info on Category: Direct Compression
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Not Available

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: It is used as Diurectic-osmotic for injectable solution, Dialysis solution, Injectible and Parenteral solution.
Ingredient(s): Mannitol
More Info on Category: Parenteral
Route of Administration (Grade): Parenteral
Pharmacopoeia Reference: Monograph- Ph.Eur, USP/NF, JP/JPE, FDA IIG
Technical Specifications: Not Available

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Use in a wide range of oral applications such as wet or dry granulation, excipient of choice for flash release forms.
Ingredient(s): Mannitol
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Topical, Oral
Pharmacopoeia Reference: Monograph- Ph.Eur, USP/NF
Technical Specifications: Available in different particle size as 25.µ, 50.µ, 180.µ

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.
Ingredient(s): Magnesium Stearate
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- Ph.Eur, USP/NF
Technical Specifications: Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.
Ingredient(s): Magnesium Stearate
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- Ph.Eur, USP/NF
Technical Specifications: Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile
Ingredient(s): Magnesium Stearate
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- Ph.Eur, USP/NF
Technical Specifications: Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • TABLET;ORAL - 0.0625MG
  • TABLET;ORAL - 0.125MG
  • TABLET;ORAL - 0.1875MG
  • TABLET;ORAL - 0.25MG
  • ELIXIR;ORAL - 0.05MG/ML
  • INJECTABLE;INJECTION - 0.1MG/ML
  • INJECTABLE;INJECTION - 0.25MG/ML
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty